Lam Research Corporation $LRCX Shares Purchased by VestGen Advisors LLC

VestGen Advisors LLC grew its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 279.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 18,332 shares of the semiconductor company’s stock after acquiring an additional 13,505 shares during the period. VestGen Advisors LLC’s holdings in Lam Research were worth $1,784,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. BLI Banque de Luxembourg Investments acquired a new position in shares of Lam Research in the 2nd quarter valued at $4,247,000. Legacy Capital Wealth Partners LLC boosted its holdings in shares of Lam Research by 2.0% in the second quarter. Legacy Capital Wealth Partners LLC now owns 6,644 shares of the semiconductor company’s stock worth $647,000 after buying an additional 131 shares during the period. West Family Investments Inc. boosted its holdings in shares of Lam Research by 63.7% in the second quarter. West Family Investments Inc. now owns 8,791 shares of the semiconductor company’s stock worth $856,000 after buying an additional 3,421 shares during the period. Mackenzie Financial Corp increased its position in shares of Lam Research by 11.2% in the second quarter. Mackenzie Financial Corp now owns 1,740,647 shares of the semiconductor company’s stock worth $169,435,000 after acquiring an additional 174,977 shares in the last quarter. Finally, Silvant Capital Management LLC raised its holdings in shares of Lam Research by 18.7% during the second quarter. Silvant Capital Management LLC now owns 62,142 shares of the semiconductor company’s stock valued at $6,049,000 after acquiring an additional 9,778 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

LRCX has been the subject of a number of recent analyst reports. Stifel Nicolaus set a $160.00 price objective on shares of Lam Research and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Wall Street Zen cut Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Berenberg Bank lifted their price target on Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Weiss Ratings reissued a “buy (b)” rating on shares of Lam Research in a research report on Monday, November 24th. Finally, The Goldman Sachs Group raised their price objective on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Twenty-six analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average target price of $152.17.

Lam Research Stock Performance

Shares of LRCX stock opened at $154.95 on Monday. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $167.15. The stock’s 50-day moving average is $147.23 and its two-hundred day moving average is $114.99. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The firm has a market cap of $194.62 billion, a P/E ratio of 34.13, a PEG ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s revenue was up 27.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Insider Activity

In other news, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is owned by company insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.